Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.
about
Bipolar disorder and mechanisms of action of mood stabilizersSubcortical volumetric abnormalities in bipolar disorderA role for a lithium-inhibited Golgi nucleotidase in skeletal development and sulfationTherapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderOn the Teneurin track: a new synaptic organization molecule emergesOverexpression of Homer1a in the basal and lateral amygdala impairs fear conditioning and induces an autism-like social impairmentMolecular actions and clinical pharmacogenetics of lithium therapySynergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibitionNFAT/Fas signaling mediates the neuronal apoptosis and motor side effects of GSK-3 inhibition in a mouse model of lithium therapyOverexpression of the type 1 adenylyl cyclase in the forebrain leads to deficits of behavioral inhibition.Genetic and pharmacological evidence for schizophrenia-related Disc1 interaction with GSK-3.Lithium and genetic inhibition of GSK3beta enhance the effect of methamphetamine on circadian rhythms in the mouseA reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to menSerotonin modulates a depression-like state in Drosophila responsive to lithium treatment.Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research.Regulation of metabolic networks by small molecule metabolites.Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation.Involvment of cytosolic and mitochondrial GSK-3beta in mitochondrial dysfunction and neuronal cell death of MPTP/MPP-treated neuronsProtein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder.Combined diffusion tensor imaging and transverse relaxometry in early-onset bipolar disorder.Animal models to improve our understanding and treatment of suicidal behaviorIs aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder.Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: a proton magnetic resonance spectroscopy studyThyroid states regulate subcellular glucose phosphorylation activity in male mice.Brain lithium, N-acetyl aspartate and myo-inositol levels in older adults with bipolar disorder treated with lithium: a lithium-7 and proton magnetic resonance spectroscopy study.Valproate alters dopamine signaling in association with induction of Par-4 protein expressionPositional cloning, association analysis and expression studies provide convergent evidence that the cadherin gene FAT contains a bipolar disorder susceptibility allele.Abnormal emotional learning in a rat model of autism exposed to valproic acid in utero.A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription.Novel drugs and therapeutic targets for severe mood disorders.Lithium induces ER stress and N-glycan modification in galactose-grown Jurkat cells.Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disordersExpression profiling in neuropsychiatric disorders: emphasis on glutamate receptors in bipolar disorderEmerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology.Molecular Signatures of Psychosocial Stress and Cognition Are Modulated by Chronic Lithium Treatment.Human Pluripotent Stem Cell-derived Cortical Neurons for High Throughput Medication Screening in Autism: A Proof of Concept Study in SHANK3 Haploinsufficiency Syndrome.Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs.Animal models of bipolar disorder and mood stabilizer efficacy: a critical need for improvement.The behavioral actions of lithium in rodent models: leads to develop novel therapeutics.The wnt pathway in mood disorders
P2860
Q22252332-553DDC19-345D-461C-B210-A2AF73DE130FQ23747500-66E91A1E-D8F9-488B-AD66-75E3175D69C4Q24322895-DFADCDAD-782F-4EFD-AC2A-CB980D3DCA2EQ24626017-FB3F2770-BFF1-4DB5-895D-9C9EC7F20A6CQ27028029-86474029-C86F-4390-854A-CC82EDB5FDDFQ27322939-BED0C214-2E89-46F9-BDBD-9E1B15BA90ADQ28307770-6F8F759F-749B-4206-8108-7D3812A4153CQ28468536-4D2574FA-62F9-40DD-AD5E-5761D4CBB6DFQ28586033-E1961EB6-4AC0-4093-AC26-5E5F410F0410Q30407430-1D059FDC-10AD-488B-8047-4CD3CC71AEA6Q30408186-492DAFE6-FCF1-45FA-A793-91E8452D9BD6Q30435752-FCBE5909-CA39-4D9B-B7FE-C234EECE2D46Q30480638-19723748-EA1D-4ADB-9977-4211A9EA154FQ30855409-93F73D30-7C72-4C9D-AAB5-AAF08202FF4AQ30995022-D32D8A55-BE3D-425C-8356-132007D4C76CQ33277970-34347D8C-1526-4D6C-A463-87BF86BF235DQ33411020-A0998E13-27FF-48E9-8396-27DC5FC5AB0AQ33442821-ABDF1B13-11F5-44D7-AD37-A0103ADDA4CCQ33573983-4D7568E5-5D4A-4304-A6CF-20BF655E529EQ33613434-284D4534-5230-4179-AFEE-A04DE0E9B356Q33635653-9E67AF89-20B0-42E8-97EF-1029CB08F921Q33637566-CB6531B0-D352-43E6-BFCE-54DF2166786AQ33796986-9B373309-0D91-444F-B60D-CCBB1C47D651Q33904219-3F7BA96A-6AEE-4503-8DB4-4EADF0BB75EDQ33908187-8C2DA66F-33DA-4B92-A75E-725D2C6C1457Q34429621-718F0202-E382-4D05-BB7F-B196CED5D048Q34482863-F106887C-1863-469E-83A3-60369279E808Q34495960-B8C73115-71ED-4839-9385-67F040250F00Q34605987-9F296934-518E-4E8D-BF6D-035CD763AA40Q34732759-E0B28574-BF93-4DD5-97F6-C0BBE8E173A1Q34876367-A1AB8435-36D1-4C9F-BC8F-7E60FEE585C3Q35197096-11902FF2-A59A-49A5-8007-62A840EB5C50Q35661134-6BE187F5-45A0-40D4-BD9F-CEC0E7DFA435Q35770190-9C500BCC-D58E-4DCC-8CEC-5CA1DD7FB92CQ35880985-D0015853-1AAB-48CD-BF1B-F05EBCE96F90Q36059026-C5F301F4-F8A6-4933-8F8B-9C35EB2002F9Q36096851-E21804DD-C112-4D7B-84B4-02D53B747317Q36293331-7A956CC5-6A1A-4BD7-A664-2A983EA67BFBQ36293345-FD476432-8E9D-48B5-90E1-504D1167771AQ36310513-2F34AAE3-EAF6-45C3-8810-63707D5A0817
P2860
Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Emerging experimental therapeu ...... s of current mood stabilizers.
@ast
Emerging experimental therapeu ...... s of current mood stabilizers.
@en
type
label
Emerging experimental therapeu ...... s of current mood stabilizers.
@ast
Emerging experimental therapeu ...... s of current mood stabilizers.
@en
prefLabel
Emerging experimental therapeu ...... s of current mood stabilizers.
@ast
Emerging experimental therapeu ...... s of current mood stabilizers.
@en
P2093
P2860
P356
P1433
P1476
Emerging experimental therapeu ...... s of current mood stabilizers.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.MP.4001518
P407
P577
2004-08-01T00:00:00Z